TSX:ONC 0.39 CAD +0.00 +0% Volume: 86,900 November 27, 2015
OTCQX:ONCYF 0.28 USD +0.00 +0% Volume: 64,833 November 27, 2015

For Investors

The Cutting Edge of Cancer Innovation

Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC) and the NASDAQ (OTCQX:ONCYF). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.


Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.

View Financials

Stock Information

View our stock charts and other information about our stock (TSX:ONC, OTCQX:ONCYF).

View Stock Information

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Investor Presentation

Click here to load our most recent investor presentation.

View Presentation

Latest News

November 18, 2015 Oncolytics Biotech® Inc. Announces Start of Enrollment in Phase 1b Study of Multiple Myeloma Looking at REOLYSIN® in Combination with Bortezomib
November 05, 2015 Oncolytics Biotech® Inc. Announces 2015 Third Quarter Results
October 29, 2015 Oncolytics Biotech® Inc. Announces Receipt of Qualification for Trading on the OTCQX and Nasdaq Notice of Delisting
Sign up to receive e-mail updates *